Literature DB >> 32220583

MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.

Xiaoqin Wu1, Kyle L Poulsen1, Carlos Sanz-Garcia1, Emily Huang1, Megan R McMullen1, Sanjoy Roychowdhury2, Srinivasan Dasarathy3, Laura E Nagy4.   

Abstract

BACKGROUND & AIMS: Autophagy maintains cellular homeostasis and plays a critical role in the development of pan class="Disease">non-alcoholic fatty liver and steatohepatitis. The pseudokinase mixed lineage kinase domain-like (MLKL) is a key downstream effector of receptor interacting protein kinase 3 (RIP3) in the necroptotic pathway of programmed cell death. However, recent data reveal that MLKL also regulates autophagy. Herein, we tested the hypothesis that MLKL contributes to the progression of Western diet-induced liver injury in mice by regulating autophagy.
METHODS: Rip3+/+, Rip3-/-, Mlkl+/+ and Mlkl-/- mice were fed a Western diet (FFC diet, high in fat, fructose and cholesterol) or chow for 12 weeks. AML12 and primary mouse hepatocytes were exposed to palmitic acid (PA).
RESULTS: The FFC diet increased expression, phosphorylation and oligomerization of MLKL in the liver. Mlkl, but not Rip3, deficiency protected mice from FFC diet-induced liver injury. The FFC diet also induced accumulation of p62 and LC3-II, as well as markers of endoplasmic reticulum stress, in Mlkl+/+ but not Mlkl-/- mice. Mlkl deficiency in mice also prevented the inhibition of autophagy by a protease inhibitor, leupeptin. Using an mRFP-GFP-LC3 reporter in cultured hepatocytes revealed that PA blocked the fusion of autophagosomes with lysosomes. PA triggered MLKL expression and translocation, first to autophagosomes and then to the plasma membrane, independently of Rip3. Mlkl, but not Rip3, deficiency prevented inhibition of autophagy in PA-treated hepatocytes. Overexpression of Mlkl blocked autophagy independently of PA. Additionally, pharmacologic inhibition of autophagy induced MLKL expression and translocation to the plasma membrane in hepatocytes.
CONCLUSIONS: Taken together, these data indicate that MLKL-dependent, but RIP3-independent, signaling contributes to FFC diet-induced liver injury by inhibiting autophagy. LAY
SUMMARY: Autophagy is a regulated process that maintains cellular homeostasis. Impaired autophagy contributes to cell injury and death, thus playing a critical role in the pathogenesis of a number of diseases, including non-alcohol-associated fatty liver and steatohepatitis. Herein, we show that Mlkl-dependent, but Rip3-independent, signaling contributed to diet-induced liver injury and inflammatory responses by inhibiting autophagy. These data identify a novel co-regulatory mechanism between necroptotic and autophagic signaling pathways in non-alcoholic fatty liver disease.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagic flux; MLKL; NAFLD; NASH; Necroptosis; RIPK3

Year:  2020        PMID: 32220583      PMCID: PMC7438259          DOI: 10.1016/j.jhep.2020.03.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  52 in total

Review 1.  Regulated necrosis: the expanding network of non-apoptotic cell death pathways.

Authors:  Tom Vanden Berghe; Andreas Linkermann; Sandrine Jouan-Lanhouet; Henning Walczak; Peter Vandenabeele
Journal:  Nat Rev Mol Cell Biol       Date:  2014-02       Impact factor: 94.444

2.  MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation.

Authors:  Seongmin Yoon; Andrew Kovalenko; Konstantin Bogdanov; David Wallach
Journal:  Immunity       Date:  2017-06-27       Impact factor: 31.745

3.  Necroptosis: (Last) Message in a Bubble.

Authors:  Peter Vandenabeele; Franck Riquet; Benjamin Cappe
Journal:  Immunity       Date:  2017-07-18       Impact factor: 31.745

4.  Function of Autophagy in Nonalcoholic Fatty Liver Disease.

Authors:  Mark J Czaja
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

5.  Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance.

Authors:  Ling Yang; Ping Li; Suneng Fu; Ediz S Calay; Gökhan S Hotamisligil
Journal:  Cell Metab       Date:  2010-06-09       Impact factor: 27.287

6.  Hepatocyte caspase-8 is an essential modulator of steatohepatitis in rodents.

Authors:  Maximilian Hatting; Gang Zhao; Fabienne Schumacher; Gernot Sellge; Malika Al Masaoudi; Nikolaus Gaβler; Mark Boekschoten; Michael Müller; Christian Liedtke; Francisco Javier Cubero; Christian Trautwein
Journal:  Hepatology       Date:  2013-05-06       Impact factor: 17.425

7.  The role of the LncRNA-FA2H-2-MLKL pathway in atherosclerosis by regulation of autophagy flux and inflammation through mTOR-dependent signaling.

Authors:  Feng-Xia Guo; Qian Wu; Pan Li; Lei Zheng; Shu Ye; Xiao-Yan Dai; Chun-Min Kang; Jing-Bo Lu; Bang-Ming Xu; Yuan-Jun Xu; Lei Xiao; Zhi-Feng Lu; Huan-Lan Bai; Yan-Wei Hu; Qian Wang
Journal:  Cell Death Differ       Date:  2019-01-25       Impact factor: 15.828

8.  Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes.

Authors:  Swati Joshi-Barve; Shirish S Barve; Kiranmayi Amancherla; Leila Gobejishvili; Daniell Hill; Matthew Cave; Prachi Hote; Craig J McClain
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

9.  The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis.

Authors:  Megan L Goodall; Brent E Fitzwalter; Shadi Zahedi; Min Wu; Diego Rodriguez; Jean M Mulcahy-Levy; Douglas R Green; Michael Morgan; Scott D Cramer; Andrew Thorburn
Journal:  Dev Cell       Date:  2016-05-23       Impact factor: 12.270

10.  TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members.

Authors:  N Vanlangenakker; M J M Bertrand; P Bogaert; P Vandenabeele; T Vanden Berghe
Journal:  Cell Death Dis       Date:  2011-11-17       Impact factor: 8.469

View more
  25 in total

1.  MLKL contributes to Western diet-induced liver injury through inhibiting autophagy.

Authors:  Xiaoqin Wu; Laura E Nagy
Journal:  Autophagy       Date:  2020-05-13       Impact factor: 16.016

Review 2.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

3.  METTL3-m6A-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.

Authors:  Zishan Peng; Yingying Gong; Xuejie Wang; Weiman He; Liting Wu; Luyao Zhang; Li Xiong; Yanrui Huang; Lei Su; Peijie Shi; Xiaopei Cao; Rengyun Liu; Yanbing Li; Haipeng Xiao
Journal:  Mol Ther       Date:  2021-09-20       Impact factor: 12.910

4.  Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.

Authors:  Ren Guo; Xiaohui Jia; Zhenbin Ding; Gang Wang; Mengmeng Jiang; Bing Li; Shanshan Chen; Bingqing Xia; Qing Zhang; Jian Liu; Ruting Zheng; Zhaobing Gao; Xin Xie
Journal:  Theranostics       Date:  2022-07-04       Impact factor: 11.600

5.  The roles of autophagy and thyroid hormone in the pathogenesis and treatment of NAFLD.

Authors:  Jin Zhou; Rohit A Sinha; Paul M Yen
Journal:  Hepatoma Res       Date:  2021-11-05

Review 6.  MLKL in cancer: more than a necroptosis regulator.

Authors:  Peter Vandenabeele; Nozomi Takahashi; Sofie Martens; Jolien Bridelance; Ria Roelandt
Journal:  Cell Death Differ       Date:  2021-05-05       Impact factor: 12.067

Review 7.  Cell Death in Liver Diseases: A Review.

Authors:  Layla Shojaie; Andrea Iorga; Lily Dara
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

Review 8.  The Role of the Key Effector of Necroptotic Cell Death, MLKL, in Mouse Models of Disease.

Authors:  Emma C Tovey Crutchfield; Sarah E Garnish; Joanne M Hildebrand
Journal:  Biomolecules       Date:  2021-05-28

Review 9.  Advances in Molecular Mechanisms for Traditional Chinese Medicine Actions in Regulating Tumor Immune Responses.

Authors:  Han Huang; Jiansong Fang; Xiude Fan; Tatsunori Miyata; Xiaoyue Hu; Lihe Zhang; Liangren Zhang; Yimin Cui; Zhenming Liu; Xiaoqin Wu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

10.  Programmed cell death in alcohol-associated liver disease.

Authors:  Tatsunori Miyata; Laura E Nagy
Journal:  Clin Mol Hepatol       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.